Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Dermatology ; 210 Suppl 1: 22-9, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15724104

RESUMEN

BACKGROUND: Retinaldehyde (RAL), a key metabolite between vitamin A and retinoic acid, acts by modulating differentiation and proliferation of keratinocytes, which is of interest in acne lesions, mainly retentional lesions. Glycolic acid increases the exfoliation of corneocytes explaining its mild activity on retentional lesions. Thus, RAL and glycolic acid combined in the same product (Diacneal) have complementary activities which can be of interest for acne patients. The aim of this study was to evaluate the tolerance of Diacneal used by 1,709 acne patients in combination with their usual acne products except retinoids. RESULTS: This study demonstrated a very good tolerance of Diacneal when used with other acne treatments for 90 days. Complaints about side-effects were rare. Moreover, the significant decrease in both inflammatory and retentional lesions between day 0 and day 90 indicates that Diacneal could amplify the efficiency of other anti-acne products used at the same time by the patients. The subjective evaluation of the preparation's efficacy by investigators and patients was strongly favourable. CONCLUSION: These data show that a combination of RAL 0.1% and glycolic acid 6% may be used in association with other topical anti-acne treatments (benzoyl peroxide and topical antibiotics) with an excellent tolerance.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Glicolatos/uso terapéutico , Queratolíticos/uso terapéutico , Retinaldehído/uso terapéutico , Administración Cutánea , Adolescente , Adulto , Niño , Fármacos Dermatológicos/administración & dosificación , Combinación de Medicamentos , Femenino , Glicolatos/administración & dosificación , Humanos , Queratolíticos/administración & dosificación , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Satisfacción del Paciente , Estudios Prospectivos , Retinaldehído/administración & dosificación , Resultado del Tratamiento , Cicatrización de Heridas/efectos de los fármacos
2.
Artículo en Inglés | MEDLINE | ID: mdl-11867969

RESUMEN

The aim of the present study was to assess the anti-inflammatory activity of two topically applied oatmeal extracts, i.e. Avena sativa and Avena Rhealba, using the sodium lauryl sulfate (SLS) irritation model. At baseline, test areas on the volar surface of the upper arms of 12 healthy individuals were pretreated with the two extracts and their vehicle (petrolatum ointment) under occlusion for 2 h, and one site was left untreated. Then a patch with a 1% SLS solution was applied to the test sites for 24 h. Irritation was determined at each period by measuring by chromametry and laser-Doppler. In a dose-ranging study with the Avena Rhealba extract alone, the 20 and 30% concentrations exerted a slight inhibition of the a* parameter increase and a marked reduction of the blood flow increase (p < 0.05, compared to vehicle). Then, the effects of the two extracts at the concentration of 20% were compared. All extracts displayed a statistically significant counteracting effect on both parameters (p < 0.05), but no statistically significant difference between treatment groups could be demonstrated. In conclusion, this study demonstrates the preventive effects of oatmeal extracts on skin irritation in the SLS model.


Asunto(s)
Avena , Fitoterapia/métodos , Pruebas de Irritación de la Piel , Dodecil Sulfato de Sodio/efectos adversos , Adulto , Análisis de Varianza , Método Doble Ciego , Femenino , Humanos , Inflamación/prevención & control , Masculino , Extractos Vegetales/uso terapéutico , Pruebas de Irritación de la Piel/métodos , Estadísticas no Paramétricas , Tensoactivos/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA